
The Top Healthcare Stocks to Buy With $100
Pfizer has important, ongoing projects that should start to pay off down the road. Doximity's strong margins, moat, and growth opportunities could mean a bright future.

Earnings Estimates Moving Higher for Doximity (DOCS): Time to Buy?
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ICLR or DOCS: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or Doximity (DOCS). But which of these two stocks offers value investors a better bang for ...

Doximity Stock Rallies. Guidance Boost 'Just What the Doctor Ordered.
The online platform for medical professionals also reported fiscal second-quarter adjusted earnings that beat analysts' estimates.

Doximity, Inc. (DOCS) Q2 2024 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Perry Gold - VP of IR Jeffrey Tangney - Co-Founder & CEO Anna Bryson - CFO Nate Gross -...

Doximity (DOCS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall...

Doctors have a new way to scrub personal information from internet after spike in harassment
Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites

MD or DOCS: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of these two stocks presents investors with the better...

1 Growth Stock Down 39% to Buy and Hold for 10 Years
Doximity's valuation and slowing sales growth are turning off many investors. Despite these issues, there is a lot to like about the company, including its moat.

3 Top Stocks That Just Went on Sale
Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth, armed with a new Lowe's partnership.

1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years
Doximity is profitable and boasts high gross and net margins. The company's platform displays the flywheel effect, a powerful moat.

Down 39.9%, Is Doximity a Buy on the Dip?
Doximity shares recently fell in response to a revised forward outlook management shared during its fiscal first-quarter earnings report. Over half a million unique U.S. physicians used Doximity's ...

Time to Cut and Run on This 1 Formerly Promising Digital Health Stock?
Doximity's revised guidance for the current fiscal year was horrendous. The business is still growing a bit and is highly profitable.

Why Doximity Stock Plunged 29% This Week
Doximity announced solid fiscal first-quarter 2024 results that exceeded expectations. But the online networking service for medical professionals is also laying off 10% of its workforce and lowere...

Why Shares of Doximity Are Falling Wednesday
Doximity said it was trimming its workforce by 10%. The company reported increased revenue and net income.
Related Companies